0000899243-21-000400.txt : 20210105 0000899243-21-000400.hdr.sgml : 20210105 20210105164409 ACCESSION NUMBER: 0000899243-21-000400 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210105 DATE AS OF CHANGE: 20210105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Koppel Adam CENTRAL INDEX KEY: 0001578965 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38535 FILM NUMBER: 21506465 MAIL ADDRESS: STREET 1: C/O BROOKSIDE CAPITAL, LLC STREET 2: JOHN HANCOCK TOWER, 200 CLARENDON ST CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptinyx Inc. CENTRAL INDEX KEY: 0001674365 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474626057 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 MAPLE AVENUE STREET 2: SUITE 4300 CITY: EVANSTON STATE: IL ZIP: 60201 BUSINESS PHONE: 847-871-0377 MAIL ADDRESS: STREET 1: 909 DAVIS STREET STREET 2: SUITE 600 CITY: EVANSTON STATE: IL ZIP: 60201 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-31 0 0001674365 Aptinyx Inc. APTX 0001578965 Koppel Adam C/O BAIN CAPITAL LIFE SCIENCES INVESTORS LLC, 200 CLARENDON STREET BOSTON MA 02116 1 0 1 0 Stock Option (Right Buy) 3.46 2020-12-31 4 A 0 5508 2.224 A 2030-12-30 Common Stock 5508 5508 D This option is fully vested at time of grant. The option award was issued to the Reporting Person, who elected to take equity awards in lieu of cash compensation for services as a director, pursuant to the Issuer's nonemployee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant. /s/ Adam Koppel 2021-01-05